Moderna Begins Vaccine Trial for Children

36
COVID-19 cases

The United States currently has the highest number of confirmed COVID-19 cases and related deaths in the world.
More than 535,000 people have died from COVID-19 in the United States.

The CDC says people who are vaccinated can meet indoors without taking physical distancing measures.
Update on COVID-19 numbers

Globally, there have been more than 120.5 million confirmed cases and more than 2.6 million associated deaths, according to Johns Hopkins University.

The United States has reported more than 29.5 million confirmed cases.

More than 536,000 people in the United States have died from the disease.

More than 72.1 million people in the United States have received their first COVID-19 vaccine dose, according to the CDC.

Healthline updates this page on weekdays. For up-to-date information about the virus, go here.

Moderna is beginning vaccine trials that include children

Moderna pharmaceutical company has begun vaccine trials on children between the ages of 6 months to 12 years. The trial is based in the United States and Canada and will evaluate how well the COVID-19 vaccines work in children.

Currently, the COVID-19 vaccines are approved only for people over age 16.

No evidence AstraZeneca vaccine caused blood clots, WHO says

Worldwide distribution of AstraZeneca’s COVID-19 vaccine remains unaffected by the jab’s suspension in much of Europe following reports of blood clots in some people shortly after vaccination, the World Health Organization (WHO) said, reported The Washington Post.

The number of blood clots reported was not higher than what would be expected in a given population.

Australia announced March 16 that it would continue to use the vaccine.

“We are aware of some further European countries pausing the use of the AstraZeneca vaccine due to reports of blood clots in people who have been vaccinated,” Australian Chief Medical Officer Dr. Paul Kelly said in a statement.

“While the European Medicines Agency is investigating these events, it has reinforced its view that the AstraZeneca COVID-19 vaccine is successful in protecting against COVID-19 and should continue to be used in the rollout,” he added.

According to the Post, WHO continues to caution against suspending access to vaccines and has also noted that no evidence links these events to the AstraZeneca COVID-19 vaccine.

LEAVE A REPLY

Please enter your comment!
Please enter your name here